Back
Emergent BioSolutions Stock Price Chart

Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
50
EBS
Emergent BioSolutions
Last Price:
$6.24
Seasonality Move:
5.76%
7 Day Trial
ALL ACCESS PASS
$
7

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bearish and EBS is experiencing slight selling pressure.
Emergent BioSolutions Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.41 | Sell |
20-day SMA: | 6.4 | Sell |
50-day SMA: | 5.74 | Buy |
200-day SMA: | 7.74 | Sell |
8-day EMA: | 6.33 | Sell |
20-day EMA: | 6.29 | Sell |
50-day EMA: | 5.54 | Buy |
200-day EMA: | 2.69 | Buy |
Emergent BioSolutions Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 49.86 | Sell |
Chaikin Money Flow: | -1159198 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.14 - 6.68) | Sell |
Bollinger Bands (100): | (4.64 - 8.5) | Sell |
Emergent BioSolutions Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Emergent BioSolutions Stock
Is Emergent BioSolutions Stock a Buy?
-
Emergent BioSolutions share price is 6.22 while EBS 8-day simple moving average is 6.41, which is a Sell signal.
-
The stock price of EBS is 6.22 while Emergent BioSolutions 20-day SMA is 6.40, which makes it a Sell.
-
Emergent BioSolutions 50-day simple moving average is 5.74 while EBS share price is 6.22, making it a Buy technically.
-
EBS stock price is 6.22 and Emergent BioSolutions 200-day simple moving average is 7.74, creating a Sell signal.
EBS Technical Analysis vs Fundamental Analysis
Sell
50
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy or a Sell?
-
Emergent BioSolutions stock is rated a SellThe current Emergent BioSolutions [EBS] share price is $6.22. The Score for EBS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Emergent BioSolutions Stock Info
Market Cap:
337.6M
Price in USD:
6.22
Share Volume:
2.5M
Emergent BioSolutions 52-Week Range
52-Week High:
15.10
52-Week Low:
4.02
Sell
50
Emergent BioSolutions (EBS)
is a Sell
Emergent BioSolutions Share Price Forecast
-
What is the Emergent BioSolutions stock price today?The Emergent BioSolutions stock price is 6.22 USD today.
-
Will EBS stock go up or go down?Emergent BioSolutions> share price is forecast to RISE/FALL based on technical indicators
-
Is Emergent BioSolutions overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Emergent BioSolutions is overvalued.
Is Emergent BioSolutions Stock a Buy?
-
Emergent BioSolutions share price is 6.22 while EBS 8-day exponential moving average is 6.33, which is a Sell signal.
-
The stock price of EBS is 6.22 while Emergent BioSolutions 20-day EMA is 6.29, which makes it a Sell.
-
Emergent BioSolutions 50-day exponential moving average is 5.54 while EBS share price is 6.22, making it a Buy technically.
-
EBS stock price is 6.22 and Emergent BioSolutions 200-day simple moving average is 2.69, creating a Buy signal.
Fundamental Analysis of Emergent BioSolutions
Is Emergent BioSolutions a good investment?
-
Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and a decrease next year of $2.03 per share.
Technical Analysis of Emergent BioSolutions
Should I short Emergent BioSolutions stock?
-
EBS Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Emergent BioSolutions is a Buy
-
Emergent BioSolutions Relative Strength Index (RSI) is 49.86, which suggest Emergent BioSolutions is oversold
-
The Bollinger Bands (25) for Emergent BioSolutions is (6.14 - 6.68), which suggest Emergent BioSolutions is a Sell
-
The Bollinger Bands (100) for Emergent BioSolutions is (4.64 - 8.5), which suggest Emergent BioSolutions is a Sell
* Emergent BioSolutions stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.